JP2003510033A - ヒト細胞遺伝子をダウンレギュレートすることにより、ヒト免疫不全ウイルス感染を阻止するための組成物および方法 - Google Patents

ヒト細胞遺伝子をダウンレギュレートすることにより、ヒト免疫不全ウイルス感染を阻止するための組成物および方法

Info

Publication number: JP2003510033A
Authority: JP; Japan
Prior art keywords: protein; seq; sequence number; cell; nucleic acid
Prior art date: 1999-09-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP2001520868A

Other languages

English (en)

Japanese (ja)

Inventor

ターニャエイ．ホルツマイアー、

スティーヴンジェイ．ダン、

Original Assignee

サブサイダリーナンバースリーインコーポレイテッド

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-01

Filing date

2000-09-01

Publication date

2003-03-18

2000-09-01 Application filed by サブサイダリーナンバースリーインコーポレイテッド filed Critical サブサイダリーナンバースリーインコーポレイテッド

2003-03-18 Publication of JP2003510033A publication Critical patent/JP2003510033A/ja

Status Pending legal-status Critical Current

Links

108090000623 proteins and genes Proteins 0.000 title claims abstract description 404
238000000034 method Methods 0.000 title claims description 77
239000000203 mixture Substances 0.000 title claims description 54
241000725303 Human immunodeficiency virus Species 0.000 title description 118
230000002401 inhibitory effect Effects 0.000 title description 20
210000005260 human cell Anatomy 0.000 title description 15
230000002222 downregulating effect Effects 0.000 title description 6
230000009385 viral infection Effects 0.000 title description 2
102000004169 proteins and genes Human genes 0.000 claims abstract description 236
150000007523 nucleic acids Chemical class 0.000 claims abstract description 150
208000031886 HIV Infections Diseases 0.000 claims abstract description 140
102000039446 nucleic acids Human genes 0.000 claims abstract description 132
108020004707 nucleic acids Proteins 0.000 claims abstract description 132
208000037357 HIV infectious disease Diseases 0.000 claims abstract description 103
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims abstract description 103
150000001875 compounds Chemical class 0.000 claims abstract description 75
230000001413 cellular effect Effects 0.000 claims abstract description 42
239000003112 inhibitor Substances 0.000 claims abstract description 37
230000001681 protective effect Effects 0.000 claims abstract description 16
210000004027 cell Anatomy 0.000 claims description 364
230000014509 gene expression Effects 0.000 claims description 86
101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 61
102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 61
230000000295 complement effect Effects 0.000 claims description 59
208000015181 infectious disease Diseases 0.000 claims description 48
230000000694 effects Effects 0.000 claims description 41
206010028980 Neoplasm Diseases 0.000 claims description 34
230000001105 regulatory effect Effects 0.000 claims description 34
239000012634 fragment Substances 0.000 claims description 32
-1 p18 protein Proteins 0.000 claims description 30
108090000765 processed proteins & peptides Proteins 0.000 claims description 26
101710205625 Capsid protein p24 Proteins 0.000 claims description 24
101710177166 Phosphoprotein Proteins 0.000 claims description 24
101710149279 Small delta antigen Proteins 0.000 claims description 24
101710147327 Calcineurin B homologous protein 1 Proteins 0.000 claims description 23
102000000013 Chemokine CCL3 Human genes 0.000 claims description 23
108091028043 Nucleic acid sequence Proteins 0.000 claims description 23
102000018679 Tacrolimus Binding Proteins Human genes 0.000 claims description 23
108010027179 Tacrolimus Binding Proteins Proteins 0.000 claims description 23
102100022563 Tubulin polymerization-promoting protein Human genes 0.000 claims description 23
238000013519 translation Methods 0.000 claims description 23
102100026901 Sorbin and SH3 domain-containing protein 2 Human genes 0.000 claims description 22
108010022535 Farnesyl-Diphosphate Farnesyltransferase Proteins 0.000 claims description 21
102100027105 Lymphocyte-specific protein 1 Human genes 0.000 claims description 21
108010006519 Molecular Chaperones Proteins 0.000 claims description 21
108010022181 Phosphopyruvate Hydratase Proteins 0.000 claims description 21
108010040838 lymphocyte-specific protein p50 Proteins 0.000 claims description 21
102100038910 Alpha-enolase Human genes 0.000 claims description 20
102000001493 Cyclophilins Human genes 0.000 claims description 20
108010068682 Cyclophilins Proteins 0.000 claims description 20
102000030782 GTP binding Human genes 0.000 claims description 20
108091000058 GTP-Binding Proteins 0.000 claims description 20
102000005431 Molecular Chaperones Human genes 0.000 claims description 20
230000027455 binding Effects 0.000 claims description 20
108010058956 Protein Phosphatase 2 Proteins 0.000 claims description 19
102000006478 Protein Phosphatase 2 Human genes 0.000 claims description 19
230000005782 double-strand break Effects 0.000 claims description 19
101710155856 C-C motif chemokine 3 Proteins 0.000 claims description 18
101100016370 Danio rerio hsp90a.1 gene Proteins 0.000 claims description 18
101100285708 Dictyostelium discoideum hspD gene Proteins 0.000 claims description 18
108010076876 Keratins Proteins 0.000 claims description 18
102000011782 Keratins Human genes 0.000 claims description 18
102000019009 Neural Cell Adhesion Molecule L1 Human genes 0.000 claims description 18
108010012255 Neural Cell Adhesion Molecule L1 Proteins 0.000 claims description 18
102000013009 Pyruvate Kinase Human genes 0.000 claims description 18
108020005115 Pyruvate Kinase Proteins 0.000 claims description 18
101100071627 Schizosaccharomyces pombe (strain 972 / ATCC 24843) swo1 gene Proteins 0.000 claims description 18
239000013604 expression vector Substances 0.000 claims description 18
108010006908 signal sequence receptor Proteins 0.000 claims description 18
230000003612 virological effect Effects 0.000 claims description 18
101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 17
102100029807 SUMO-conjugating enzyme UBC9 Human genes 0.000 claims description 17
102000012012 beta Karyopherins Human genes 0.000 claims description 17
108010075890 beta Karyopherins Proteins 0.000 claims description 17
101800000857 p40 protein Proteins 0.000 claims description 17
108010029607 4-nitrophenyl-alpha-glucosidase Proteins 0.000 claims description 16
230000033616 DNA repair Effects 0.000 claims description 16
101000629638 Homo sapiens Sorbin and SH3 domain-containing protein 2 Proteins 0.000 claims description 16
102100024442 60S ribosomal protein L13 Human genes 0.000 claims description 15
108090000654 Bone morphogenetic protein 1 Proteins 0.000 claims description 15
102100032912 CD44 antigen Human genes 0.000 claims description 15
101001118201 Homo sapiens 60S ribosomal protein L13 Proteins 0.000 claims description 15
101710154607 Azurocidin Proteins 0.000 claims description 14
108010056891 Calnexin Proteins 0.000 claims description 14
102100021868 Calnexin Human genes 0.000 claims description 14
102100030667 Eukaryotic peptide chain release factor subunit 1 Human genes 0.000 claims description 13
102000027450 oncoproteins Human genes 0.000 claims description 13
108091008819 oncoproteins Proteins 0.000 claims description 13
101710175705 Eukaryotic peptide chain release factor subunit 1 Proteins 0.000 claims description 12
101000933603 Rattus norvegicus Protein BTG1 Proteins 0.000 claims description 12
101000580041 Rattus norvegicus Ras-specific guanine nucleotide-releasing factor 1 Proteins 0.000 claims description 11
238000000338 in vitro Methods 0.000 claims description 10
238000001727 in vivo Methods 0.000 claims description 10
239000003488 releasing hormone Substances 0.000 claims description 10
108700005075 Regulator Genes Proteins 0.000 claims description 9
238000012360 testing method Methods 0.000 claims description 9
102000034534 Cotransporters Human genes 0.000 claims description 8
108020003264 Cotransporters Proteins 0.000 claims description 8
102000018697 Membrane Proteins Human genes 0.000 claims description 8
108010052285 Membrane Proteins Proteins 0.000 claims description 8
230000000903 blocking effect Effects 0.000 claims description 8
230000005764 inhibitory process Effects 0.000 claims description 8
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 7
102100023778 Corepressor interacting with RBPJ 1 Human genes 0.000 claims description 7
101000906759 Homo sapiens Corepressor interacting with RBPJ 1 Proteins 0.000 claims description 7
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 7
239000000546 pharmaceutical excipient Substances 0.000 claims description 6
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 5
239000003102 growth factor Substances 0.000 claims description 5
229920000669 heparin Polymers 0.000 claims description 5
229960002897 heparin Drugs 0.000 claims description 5
230000008676 import Effects 0.000 claims description 5
230000002942 anti-growth Effects 0.000 claims description 4
239000000969 carrier Substances 0.000 claims description 4
102000014914 Carrier Proteins Human genes 0.000 claims description 3
108091008324 binding proteins Proteins 0.000 claims description 3
210000000988 bone and bone Anatomy 0.000 claims description 3
102000022382 heparin binding proteins Human genes 0.000 claims description 3
108091012216 heparin binding proteins Proteins 0.000 claims description 3
210000004962 mammalian cell Anatomy 0.000 claims description 3
230000008439 repair process Effects 0.000 claims description 3
102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims description 2
108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims description 2
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 2
230000033228 biological regulation Effects 0.000 claims description 2
230000009467 reduction Effects 0.000 claims description 2
102100030009 Azurocidin Human genes 0.000 claims 5
102000004152 Bone morphogenetic protein 1 Human genes 0.000 claims 5
102000002067 Protein Subunits Human genes 0.000 claims 2
108010001267 Protein Subunits Proteins 0.000 claims 2
101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 claims 1
101710132457 Protein A1 Proteins 0.000 claims 1
208000025865 Ulcer Diseases 0.000 claims 1
230000000921 morphogenic effect Effects 0.000 claims 1
230000000392 somatic effect Effects 0.000 claims 1
231100000397 ulcer Toxicity 0.000 claims 1
238000007423 screening assay Methods 0.000 abstract description 2
230000000754 repressing effect Effects 0.000 abstract 1
235000018102 proteins Nutrition 0.000 description 163
239000013598 vector Substances 0.000 description 54
230000010076 replication Effects 0.000 description 50
239000000047 product Substances 0.000 description 39
241000713772 Human immunodeficiency virus 1 Species 0.000 description 36
239000002299 complementary DNA Substances 0.000 description 35
108020004999 messenger RNA Proteins 0.000 description 35
108020004414 DNA Proteins 0.000 description 33
230000000692 anti-sense effect Effects 0.000 description 33
108091032973 (ribonucleotides)n+m Proteins 0.000 description 31
210000001744 T-lymphocyte Anatomy 0.000 description 31
102000006746 NADH Dehydrogenase Human genes 0.000 description 27
108010086428 NADH Dehydrogenase Proteins 0.000 description 27
102100031063 Protein STPG4 Human genes 0.000 description 27
101710137284 Protein STPG4 Proteins 0.000 description 27
241000700605 Viruses Species 0.000 description 25
230000014616 translation Effects 0.000 description 23
239000003814 drug Substances 0.000 description 22
108060008682 Tumor Necrosis Factor Proteins 0.000 description 20
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 20
230000006870 function Effects 0.000 description 20
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 19
108091007960 PI3Ks Proteins 0.000 description 19
102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 19
108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 19
150000001413 amino acids Chemical class 0.000 description 18
125000003729 nucleotide group Chemical group 0.000 description 16
102000004196 processed proteins & peptides Human genes 0.000 description 16
102000010292 Peptide Elongation Factor 1 Human genes 0.000 description 15
108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 15
101710149136 Protein Vpr Proteins 0.000 description 15
230000006698 induction Effects 0.000 description 15
239000013612 plasmid Substances 0.000 description 15
102000006589 Alpha-ketoglutarate dehydrogenase Human genes 0.000 description 14
108020004306 Alpha-ketoglutarate dehydrogenase Proteins 0.000 description 14
230000015572 biosynthetic process Effects 0.000 description 14
230000003834 intracellular effect Effects 0.000 description 14
239000002773 nucleotide Substances 0.000 description 14
239000011734 sodium Substances 0.000 description 14
230000001225 therapeutic effect Effects 0.000 description 14
108091023025 thyroid hormone binding Proteins 0.000 description 14
102000028501 thyroid hormone-binding Human genes 0.000 description 14
210000001519 tissue Anatomy 0.000 description 14
OUQPTBCOEKUHBH-LSDHQDQOSA-N 4-[2-[4-[(e)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]phenoxy]ethyl]morpholine Chemical compound C=1C=C(C(CCC2(C)C)(C)C)C2=CC=1C(/C)=C/C(C=C1)=CC=C1OCCN1CCOCC1 OUQPTBCOEKUHBH-LSDHQDQOSA-N 0.000 description 13
102000004190 Enzymes Human genes 0.000 description 13
108090000790 Enzymes Proteins 0.000 description 13
102000008016 Eukaryotic Initiation Factor-3 Human genes 0.000 description 13
108010089790 Eukaryotic Initiation Factor-3 Proteins 0.000 description 13
102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 13
229940088598 enzyme Drugs 0.000 description 13
230000001965 increasing effect Effects 0.000 description 13
230000004048 modification Effects 0.000 description 13
238000012986 modification Methods 0.000 description 13
229950008012 mofarotene Drugs 0.000 description 13
108020000494 protein-tyrosine phosphatase Proteins 0.000 description 13
102000005962 receptors Human genes 0.000 description 13
108020003175 receptors Proteins 0.000 description 13
208000030507 AIDS Diseases 0.000 description 12
210000002472 endoplasmic reticulum Anatomy 0.000 description 12
239000000243 solution Substances 0.000 description 12
102100023818 ADP-ribosylation factor 3 Human genes 0.000 description 11
102100028728 Bone morphogenetic protein 1 Human genes 0.000 description 11
102000005877 Peptide Initiation Factors Human genes 0.000 description 11
108010044843 Peptide Initiation Factors Proteins 0.000 description 11
101710090322 Truncated surface protein Proteins 0.000 description 11
102100021013 Ubiquitin carboxyl-terminal hydrolase 7 Human genes 0.000 description 11
101710167638 Ubiquitin carboxyl-terminal hydrolase 7 Proteins 0.000 description 11
235000001014 amino acid Nutrition 0.000 description 11
229940079593 drug Drugs 0.000 description 11
238000002347 injection Methods 0.000 description 11
239000007924 injection Substances 0.000 description 11
230000008569 process Effects 0.000 description 11
230000001177 retroviral effect Effects 0.000 description 11
108090000994 Catalytic RNA Proteins 0.000 description 10
102000053642 Catalytic RNA Human genes 0.000 description 10
108091026890 Coding region Proteins 0.000 description 10
108091092562 ribozyme Proteins 0.000 description 10
239000000758 substrate Substances 0.000 description 10
101710139744 ADP-ribosylation factor 3 Proteins 0.000 description 9
239000012131 assay buffer Substances 0.000 description 9
238000009472 formulation Methods 0.000 description 9
102000043635 human AZU1 Human genes 0.000 description 9
229910052588 hydroxylapatite Inorganic materials 0.000 description 9
239000002502 liposome Substances 0.000 description 9
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 9
230000026731 phosphorylation Effects 0.000 description 9
238000006366 phosphorylation reaction Methods 0.000 description 9
229920001184 polypeptide Polymers 0.000 description 9
108020005544 Antisense RNA Proteins 0.000 description 8
102000053602 DNA Human genes 0.000 description 8
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 8
108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 8
102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 description 8
230000004913 activation Effects 0.000 description 8
239000002585 base Substances 0.000 description 8
238000009396 hybridization Methods 0.000 description 8
210000000265 leukocyte Anatomy 0.000 description 8
238000004519 manufacturing process Methods 0.000 description 8
238000003752 polymerase chain reaction Methods 0.000 description 8
230000002062 proliferating effect Effects 0.000 description 8
239000000725 suspension Substances 0.000 description 8
238000013518 transcription Methods 0.000 description 8
230000035897 transcription Effects 0.000 description 8
230000032258 transport Effects 0.000 description 8
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 8
241001430294 unidentified retrovirus Species 0.000 description 8
ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 7
ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 7
101000700402 Homo sapiens Regulatory solute carrier protein family 1 member 1 Proteins 0.000 description 7
241001465754 Metazoa Species 0.000 description 7
238000012408 PCR amplification Methods 0.000 description 7
102100029521 Regulatory solute carrier protein family 1 member 1 Human genes 0.000 description 7
230000036436 anti-hiv Effects 0.000 description 7
238000003556 assay Methods 0.000 description 7
239000003184 complementary RNA Substances 0.000 description 7
239000006184 cosolvent Substances 0.000 description 7
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 7
238000005516 engineering process Methods 0.000 description 7
230000014759 maintenance of location Effects 0.000 description 7
230000001404 mediated effect Effects 0.000 description 7
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 7
239000002953 phosphate buffered saline Substances 0.000 description 7
239000000126 substance Substances 0.000 description 7
230000005945 translocation Effects 0.000 description 7
238000011282 treatment Methods 0.000 description 7
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 6
108700012434 CCL3 Proteins 0.000 description 6
108020004635 Complementary DNA Proteins 0.000 description 6
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
238000000636 Northern blotting Methods 0.000 description 6
101710089386 Sorbin and SH3 domain-containing protein 2 Proteins 0.000 description 6
238000004458 analytical method Methods 0.000 description 6
239000002775 capsule Substances 0.000 description 6
238000005119 centrifugation Methods 0.000 description 6
210000000349 chromosome Anatomy 0.000 description 6
230000003828 downregulation Effects 0.000 description 6
238000001415 gene therapy Methods 0.000 description 6
230000002209 hydrophobic effect Effects 0.000 description 6
230000001939 inductive effect Effects 0.000 description 6
230000003993 interaction Effects 0.000 description 6
230000037361 pathway Effects 0.000 description 6
239000008194 pharmaceutical composition Substances 0.000 description 6
239000000523 sample Substances 0.000 description 6
238000006467 substitution reaction Methods 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 5
108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 5
102000009410 Chemokine receptor Human genes 0.000 description 5
108050000299 Chemokine receptor Proteins 0.000 description 5
108091006027 G proteins Proteins 0.000 description 5
108010010803 Gelatin Proteins 0.000 description 5
108010056771 Glucosidases Proteins 0.000 description 5
102000004366 Glucosidases Human genes 0.000 description 5
102000003886 Glycoproteins Human genes 0.000 description 5
108090000288 Glycoproteins Proteins 0.000 description 5
101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 5
102100034349 Integrase Human genes 0.000 description 5
108010077850 Nuclear Localization Signals Proteins 0.000 description 5
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 5
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 5
108010029485 Protein Isoforms Proteins 0.000 description 5
102000001708 Protein Isoforms Human genes 0.000 description 5
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 5
240000004808 Saccharomyces cerevisiae Species 0.000 description 5
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
229920002472 Starch Polymers 0.000 description 5
108050003387 Stathmin Proteins 0.000 description 5
102100040247 Tumor necrosis factor Human genes 0.000 description 5
108090000848 Ubiquitin Proteins 0.000 description 5
102000044159 Ubiquitin Human genes 0.000 description 5
238000000137 annealing Methods 0.000 description 5
239000000872 buffer Substances 0.000 description 5
230000004663 cell proliferation Effects 0.000 description 5
230000008859 change Effects 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
230000001419 dependent effect Effects 0.000 description 5
238000013461 design Methods 0.000 description 5
238000011161 development Methods 0.000 description 5
230000018109 developmental process Effects 0.000 description 5
239000003623 enhancer Substances 0.000 description 5
238000000684 flow cytometry Methods 0.000 description 5
108020001507 fusion proteins Proteins 0.000 description 5
102000037865 fusion proteins Human genes 0.000 description 5
239000008273 gelatin Substances 0.000 description 5
229920000159 gelatin Polymers 0.000 description 5
235000019322 gelatine Nutrition 0.000 description 5
235000011852 gelatine desserts Nutrition 0.000 description 5
210000003958 hematopoietic stem cell Anatomy 0.000 description 5
238000003780 insertion Methods 0.000 description 5
230000037431 insertion Effects 0.000 description 5
238000002955 isolation Methods 0.000 description 5
210000002540 macrophage Anatomy 0.000 description 5
239000003550 marker Substances 0.000 description 5
239000002609 medium Substances 0.000 description 5
230000002438 mitochondrial effect Effects 0.000 description 5
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 5
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 5
210000004940 nucleus Anatomy 0.000 description 5
229920001223 polyethylene glycol Polymers 0.000 description 5
102000040430 polynucleotide Human genes 0.000 description 5
108091033319 polynucleotide Proteins 0.000 description 5
239000002157 polynucleotide Substances 0.000 description 5
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
239000001267 polyvinylpyrrolidone Substances 0.000 description 5
229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
235000000346 sugar Nutrition 0.000 description 5
229940124597 therapeutic agent Drugs 0.000 description 5
238000001890 transfection Methods 0.000 description 5
241000701161 unidentified adenovirus Species 0.000 description 5
230000029812 viral genome replication Effects 0.000 description 5
239000013603 viral vector Substances 0.000 description 5
108091035707 Consensus sequence Proteins 0.000 description 4
102100029716 DnaJ homolog subfamily A member 3, mitochondrial Human genes 0.000 description 4
241000588724 Escherichia coli Species 0.000 description 4
101000866012 Homo sapiens DnaJ homolog subfamily A member 3, mitochondrial Proteins 0.000 description 4
102000003839 Human Proteins Human genes 0.000 description 4
108090000144 Human Proteins Proteins 0.000 description 4
108010074328 Interferon-gamma Proteins 0.000 description 4
108700026244 Open Reading Frames Proteins 0.000 description 4
108091000080 Phosphotransferase Proteins 0.000 description 4
239000002202 Polyethylene glycol Substances 0.000 description 4
101710150344 Protein Rev Proteins 0.000 description 4
101710149951 Protein Tat Proteins 0.000 description 4
108010067390 Viral Proteins Proteins 0.000 description 4
238000007792 addition Methods 0.000 description 4
VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 description 4
239000000427 antigen Substances 0.000 description 4
108091007433 antigens Proteins 0.000 description 4
102000036639 antigens Human genes 0.000 description 4
238000013459 approach Methods 0.000 description 4
239000007864 aqueous solution Substances 0.000 description 4
210000001185 bone marrow Anatomy 0.000 description 4
210000004556 brain Anatomy 0.000 description 4
230000022159 cartilage development Effects 0.000 description 4
238000004113 cell culture Methods 0.000 description 4
230000033077 cellular process Effects 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
238000010367 cloning Methods 0.000 description 4
210000000805 cytoplasm Anatomy 0.000 description 4
230000007423 decrease Effects 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
238000012217 deletion Methods 0.000 description 4
230000037430 deletion Effects 0.000 description 4
239000008298 dragée Substances 0.000 description 4
210000003527 eukaryotic cell Anatomy 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
230000004927 fusion Effects 0.000 description 4
BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 4
239000008103 glucose Substances 0.000 description 4
230000000977 initiatory effect Effects 0.000 description 4
210000004185 liver Anatomy 0.000 description 4
239000012528 membrane Substances 0.000 description 4
238000004806 packaging method and process Methods 0.000 description 4
239000008188 pellet Substances 0.000 description 4
210000005259 peripheral blood Anatomy 0.000 description 4
239000011886 peripheral blood Substances 0.000 description 4
239000012071 phase Substances 0.000 description 4
102000020233 phosphotransferase Human genes 0.000 description 4
238000001243 protein synthesis Methods 0.000 description 4
230000019491 signal transduction Effects 0.000 description 4
230000011664 signaling Effects 0.000 description 4
239000003381 stabilizer Substances 0.000 description 4
235000019698 starch Nutrition 0.000 description 4
239000006228 supernatant Substances 0.000 description 4
238000013268 sustained release Methods 0.000 description 4
239000012730 sustained-release form Substances 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
239000003826 tablet Substances 0.000 description 4
FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
102000004127 Cytokines Human genes 0.000 description 3
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 3
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
108700024394 Exon Proteins 0.000 description 3
108010066605 Geranylgeranyl-Diphosphate Geranylgeranyltransferase Proteins 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 description 3
241000282412 Homo Species 0.000 description 3
101000684275 Homo sapiens ADP-ribosylation factor 3 Proteins 0.000 description 3
101001016865 Homo sapiens Heat shock protein HSP 90-alpha Proteins 0.000 description 3
102100037850 Interferon gamma Human genes 0.000 description 3
108010050904 Interferons Proteins 0.000 description 3
102000014150 Interferons Human genes 0.000 description 3
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 description 3
102000035195 Peptidases Human genes 0.000 description 3
108091005804 Peptidases Proteins 0.000 description 3
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 3
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 3
239000004365 Protease Substances 0.000 description 3
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 3
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 3
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
108091006277 SLC5A1 Proteins 0.000 description 3
102100024237 Stathmin Human genes 0.000 description 3
102100037667 TNFAIP3-interacting protein 1 Human genes 0.000 description 3
101710149776 TNFAIP3-interacting protein 1 Proteins 0.000 description 3
108020005038 Terminator Codon Proteins 0.000 description 3
AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 3
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
230000009471 action Effects 0.000 description 3
239000004480 active ingredient Substances 0.000 description 3
102000009899 alpha Karyopherins Human genes 0.000 description 3
108010077099 alpha Karyopherins Proteins 0.000 description 3
230000006907 apoptotic process Effects 0.000 description 3
210000003719 b-lymphocyte Anatomy 0.000 description 3
230000003197 catalytic effect Effects 0.000 description 3
210000000170 cell membrane Anatomy 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
230000006378 damage Effects 0.000 description 3
239000002552 dosage form Substances 0.000 description 3
239000000839 emulsion Substances 0.000 description 3
239000012091 fetal bovine serum Substances 0.000 description 3
239000000499 gel Substances 0.000 description 3
230000013595 glycosylation Effects 0.000 description 3
238000006206 glycosylation reaction Methods 0.000 description 3
210000002216 heart Anatomy 0.000 description 3
230000007062 hydrolysis Effects 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
238000007901 in situ hybridization Methods 0.000 description 3
210000003734 kidney Anatomy 0.000 description 3
239000008101 lactose Substances 0.000 description 3
239000003446 ligand Substances 0.000 description 3
UQRORFVVSGFNRO-UTINFBMNSA-N miglustat Chemical compound CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO UQRORFVVSGFNRO-UTINFBMNSA-N 0.000 description 3
229960001512 miglustat Drugs 0.000 description 3
238000002156 mixing Methods 0.000 description 3
210000003098 myoblast Anatomy 0.000 description 3
230000012223 nuclear import Effects 0.000 description 3
230000011164 ossification Effects 0.000 description 3
230000002018 overexpression Effects 0.000 description 3
230000036470 plasma concentration Effects 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
239000000843 powder Substances 0.000 description 3
238000012545 processing Methods 0.000 description 3
230000035755 proliferation Effects 0.000 description 3
101150114778 rad21 gene Proteins 0.000 description 3
238000003259 recombinant expression Methods 0.000 description 3
229940055619 selenocysteine Drugs 0.000 description 3
ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 3
235000016491 selenocysteine Nutrition 0.000 description 3
150000003384 small molecules Chemical class 0.000 description 3
239000000600 sorbitol Substances 0.000 description 3
239000008107 starch Substances 0.000 description 3
210000000130 stem cell Anatomy 0.000 description 3
150000008163 sugars Chemical class 0.000 description 3
239000004094 surface-active agent Substances 0.000 description 3
238000007910 systemic administration Methods 0.000 description 3
210000001550 testis Anatomy 0.000 description 3
231100000331 toxic Toxicity 0.000 description 3
230000002588 toxic effect Effects 0.000 description 3
238000010361 transduction Methods 0.000 description 3
230000026683 transduction Effects 0.000 description 3
230000014621 translational initiation Effects 0.000 description 3
239000003981 vehicle Substances 0.000 description 3
210000002845 virion Anatomy 0.000 description 3
239000011534 wash buffer Substances 0.000 description 3
KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
102000007469 Actins Human genes 0.000 description 2
108020004491 Antisense DNA Proteins 0.000 description 2
102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 2
102100024504 Bone morphogenetic protein 3 Human genes 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 2
101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
102000000844 Cell Surface Receptors Human genes 0.000 description 2
108010001857 Cell Surface Receptors Proteins 0.000 description 2
108020004705 Codon Proteins 0.000 description 2
102100033779 Collagen alpha-4(IV) chain Human genes 0.000 description 2
229930105110 Cyclosporin A Natural products 0.000 description 2
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
108010036949 Cyclosporine Proteins 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
101100411547 Danio rerio rad21a gene Proteins 0.000 description 2
101710088194 Dehydrogenase Proteins 0.000 description 2
229940124186 Dehydrogenase inhibitor Drugs 0.000 description 2
108010008532 Deoxyribonuclease I Proteins 0.000 description 2
102100030012 Deoxyribonuclease-1 Human genes 0.000 description 2
241000702421 Dependoparvovirus Species 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
108091035710 E-box Proteins 0.000 description 2
108091006149 Electron carriers Proteins 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
241000710188 Encephalomyocarditis virus Species 0.000 description 2
YPZRHBJKEMOYQH-UYBVJOGSSA-N FADH2 Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1COP(O)(=O)OP(O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C(NC(=O)NC2=O)=C2NC2=C1C=C(C)C(C)=C2 YPZRHBJKEMOYQH-UYBVJOGSSA-N 0.000 description 2
102000034286 G proteins Human genes 0.000 description 2
108010067218 Guanine Nucleotide Exchange Factors Proteins 0.000 description 2
102000016285 Guanine Nucleotide Exchange Factors Human genes 0.000 description 2
239000012981 Hank's balanced salt solution Substances 0.000 description 2
241000238631 Hexapoda Species 0.000 description 2
101000695352 Homo sapiens Bone morphogenetic protein 1 Proteins 0.000 description 2
101000762375 Homo sapiens Bone morphogenetic protein 3 Proteins 0.000 description 2
101000710870 Homo sapiens Collagen alpha-4(IV) chain Proteins 0.000 description 2
101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 2
101001087412 Homo sapiens Tyrosine-protein phosphatase non-receptor type 18 Proteins 0.000 description 2
101000802094 Homo sapiens mRNA decay activator protein ZFP36L1 Proteins 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
108700002232 Immediate-Early Genes Proteins 0.000 description 2
125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
102100025169 Max-binding protein MNT Human genes 0.000 description 2
108020005196 Mitochondrial DNA Proteins 0.000 description 2
PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 2
241001529936 Murinae Species 0.000 description 2
108010066154 Nuclear Export Signals Proteins 0.000 description 2
101710163270 Nuclease Proteins 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
108700020796 Oncogene Proteins 0.000 description 2
108010033276 Peptide Fragments Proteins 0.000 description 2
102000007079 Peptide Fragments Human genes 0.000 description 2
102000003923 Protein Kinase C Human genes 0.000 description 2
108090000315 Protein Kinase C Proteins 0.000 description 2
102100034911 Pyruvate kinase PKM Human genes 0.000 description 2
REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
102000004389 Ribonucleoproteins Human genes 0.000 description 2
108010081734 Ribonucleoproteins Proteins 0.000 description 2
230000018199 S phase Effects 0.000 description 2
108020004487 Satellite DNA Proteins 0.000 description 2
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
102000058090 Sodium-Glucose Transporter 1 Human genes 0.000 description 2
108091081024 Start codon Proteins 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
101800001690 Transmembrane protein gp41 Proteins 0.000 description 2
102100033018 Tyrosine-protein phosphatase non-receptor type 18 Human genes 0.000 description 2
102000018686 U4-U6 Small Nuclear Ribonucleoprotein Human genes 0.000 description 2
108010091808 U4-U6 Small Nuclear Ribonucleoprotein Proteins 0.000 description 2
102000018390 Ubiquitin-Specific Proteases Human genes 0.000 description 2
108010066496 Ubiquitin-Specific Proteases Proteins 0.000 description 2
229930003316 Vitamin D Natural products 0.000 description 2
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
230000006978 adaptation Effects 0.000 description 2
230000002411 adverse Effects 0.000 description 2
239000000443 aerosol Substances 0.000 description 2
SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
230000003321 amplification Effects 0.000 description 2
238000010171 animal model Methods 0.000 description 2
230000001028 anti-proliverative effect Effects 0.000 description 2
239000003816 antisense DNA Substances 0.000 description 2
239000011324 bead Substances 0.000 description 2
238000009835 boiling Methods 0.000 description 2
238000010804 cDNA synthesis Methods 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
210000000845 cartilage Anatomy 0.000 description 2
230000022131 cell cycle Effects 0.000 description 2
230000030833 cell death Effects 0.000 description 2
230000024245 cell differentiation Effects 0.000 description 2
230000003915 cell function Effects 0.000 description 2
230000010261 cell growth Effects 0.000 description 2
230000010307 cell transformation Effects 0.000 description 2
108091092356 cellular DNA Proteins 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
229960001265 ciclosporin Drugs 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
238000000576 coating method Methods 0.000 description 2
238000010276 construction Methods 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
239000008121 dextrose Substances 0.000 description 2
235000014113 dietary fatty acids Nutrition 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 2
239000003937 drug carrier Substances 0.000 description 2
238000009509 drug development Methods 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
239000000284 extract Substances 0.000 description 2
239000000194 fatty acid Substances 0.000 description 2
229930195729 fatty acid Natural products 0.000 description 2
239000010685 fatty oil Substances 0.000 description 2
102000034356 gene-regulatory proteins Human genes 0.000 description 2
108091006104 gene-regulatory proteins Proteins 0.000 description 2
230000034659 glycolysis Effects 0.000 description 2
230000012010 growth Effects 0.000 description 2
239000000833 heterodimer Substances 0.000 description 2
102000048851 human CD44 Human genes 0.000 description 2
229920002674 hyaluronan Polymers 0.000 description 2
229940099552 hyaluronan Drugs 0.000 description 2
KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 2
238000003125 immunofluorescent labeling Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000002458 infectious effect Effects 0.000 description 2
229940079322 interferon Drugs 0.000 description 2
238000007918 intramuscular administration Methods 0.000 description 2
238000007912 intraperitoneal administration Methods 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
208000032839 leukemia Diseases 0.000 description 2
FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 2
239000007788 liquid Substances 0.000 description 2
230000004807 localization Effects 0.000 description 2
PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 2
229960004844 lovastatin Drugs 0.000 description 2
QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
210000004698 lymphocyte Anatomy 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000000463 material Substances 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
210000003470 mitochondria Anatomy 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
238000002703 mutagenesis Methods 0.000 description 2
231100000350 mutagenesis Toxicity 0.000 description 2
230000035772 mutation Effects 0.000 description 2
108700024542 myc Genes Proteins 0.000 description 2
239000013642 negative control Substances 0.000 description 2
210000000440 neutrophil Anatomy 0.000 description 2
238000010606 normalization Methods 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
239000003921 oil Substances 0.000 description 2
235000019198 oils Nutrition 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
239000003791 organic solvent mixture Substances 0.000 description 2
230000010627 oxidative phosphorylation Effects 0.000 description 2
238000007911 parenteral administration Methods 0.000 description 2
230000008506 pathogenesis Effects 0.000 description 2
239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
239000000816 peptidomimetic Substances 0.000 description 2
239000000825 pharmaceutical preparation Substances 0.000 description 2
WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
239000000049 pigment Substances 0.000 description 2
230000008488 polyadenylation Effects 0.000 description 2
239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
229940068968 polysorbate 80 Drugs 0.000 description 2
229920000053 polysorbate 80 Polymers 0.000 description 2
239000011148 porous material Substances 0.000 description 2
230000004481 post-translational protein modification Effects 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
239000002243 precursor Substances 0.000 description 2
230000002265 prevention Effects 0.000 description 2
210000001236 prokaryotic cell Anatomy 0.000 description 2
235000019419 proteases Nutrition 0.000 description 2
239000000700 radioactive tracer Substances 0.000 description 2
108010043277 recombinant soluble CD4 Proteins 0.000 description 2
GKBMIFPNPOSTHB-BJBKLNMKSA-N recombinant soluble cd4 Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O GKBMIFPNPOSTHB-BJBKLNMKSA-N 0.000 description 2
238000011084 recovery Methods 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000022983 regulation of cell cycle Effects 0.000 description 2
230000014493 regulation of gene expression Effects 0.000 description 2
230000003362 replicative effect Effects 0.000 description 2
229930002330 retinoic acid Natural products 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
102220246663 rs1555775209 Human genes 0.000 description 2
230000007017 scission Effects 0.000 description 2
238000012163 sequencing technique Methods 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000007787 solid Substances 0.000 description 2
230000000087 stabilizing effect Effects 0.000 description 2
238000010186 staining Methods 0.000 description 2
230000007019 strand scission Effects 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
210000003518 stress fiber Anatomy 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
230000008093 supporting effect Effects 0.000 description 2
230000002194 synthesizing effect Effects 0.000 description 2
239000000454 talc Substances 0.000 description 2
229910052623 talc Inorganic materials 0.000 description 2
235000012222 talc Nutrition 0.000 description 2
230000008685 targeting Effects 0.000 description 2
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
210000001541 thymus gland Anatomy 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
229960001727 tretinoin Drugs 0.000 description 2
230000004102 tricarboxylic acid cycle Effects 0.000 description 2
241001529453 unidentified herpesvirus Species 0.000 description 2
230000017613 viral reproduction Effects 0.000 description 2
235000019166 vitamin D Nutrition 0.000 description 2
239000011710 vitamin D Substances 0.000 description 2
150000003710 vitamin D derivatives Chemical class 0.000 description 2
229940046008 vitamin d Drugs 0.000 description 2
238000005406 washing Methods 0.000 description 2
QGVLYPPODPLXMB-UBTYZVCOSA-N (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-5H-cyclopropa[3,4]benzo[1,2-e]azulen-5-one Chemical compound C1=C(CO)C[C@]2(O)C(=O)C(C)=C[C@H]2[C@@]2(O)[C@H](C)[C@@H](O)[C@@]3(O)C(C)(C)[C@H]3[C@@H]21 QGVLYPPODPLXMB-UBTYZVCOSA-N 0.000 description 1
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
YHPKGSLWSUCJQK-UHFFFAOYSA-N 2-[[2-[[2-[[2-[[2-[[2-[[5-amino-2-[[2-[(2,4-diamino-4-oxobutanoyl)amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino) Chemical compound NC(N)=NCCCC(C(=O)NC(C(C)C)C(O)=O)NC(=O)C(CC(O)=O)NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(N)CC(N)=O YHPKGSLWSUCJQK-UHFFFAOYSA-N 0.000 description 1
HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
108050003384 2-oxoglutarate dehydrogenase E1 component Proteins 0.000 description 1
102100026936 2-oxoglutarate dehydrogenase, mitochondrial Human genes 0.000 description 1
HHDUMDVQUCBCEY-UHFFFAOYSA-N 4-[10,15,20-tris(4-carboxyphenyl)-21,23-dihydroporphyrin-5-yl]benzoic acid Chemical compound OC(=O)c1ccc(cc1)-c1c2ccc(n2)c(-c2ccc(cc2)C(O)=O)c2ccc([nH]2)c(-c2ccc(cc2)C(O)=O)c2ccc(n2)c(-c2ccc(cc2)C(O)=O)c2ccc1[nH]2 HHDUMDVQUCBCEY-UHFFFAOYSA-N 0.000 description 1
101710144734 48 kDa protein Proteins 0.000 description 1
FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 1
102100021671 60S ribosomal protein L29 Human genes 0.000 description 1
DVKQVRZMKBDMDH-UUOKFMHZSA-N 8-Br-cAMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1Br DVKQVRZMKBDMDH-UUOKFMHZSA-N 0.000 description 1
230000002407 ATP formation Effects 0.000 description 1
108091006112 ATPases Proteins 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
101100116283 Arabidopsis thaliana DD11 gene Proteins 0.000 description 1
241000271566 Aves Species 0.000 description 1
208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
102000000131 Beta tubulin Human genes 0.000 description 1
102100023995 Beta-nerve growth factor Human genes 0.000 description 1
108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 1
206010065553 Bone marrow failure Diseases 0.000 description 1
102100031151 C-C chemokine receptor type 2 Human genes 0.000 description 1
101710149815 C-C chemokine receptor type 2 Proteins 0.000 description 1
102100024167 C-C chemokine receptor type 3 Human genes 0.000 description 1
101710149862 C-C chemokine receptor type 3 Proteins 0.000 description 1
102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 1
108010041397 CD4 Antigens Proteins 0.000 description 1
101100504103 Caenorhabditis elegans gpb-2 gene Proteins 0.000 description 1
241000282465 Canis Species 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
206010057248 Cell death Diseases 0.000 description 1
206010008342 Cervix carcinoma Diseases 0.000 description 1
101710086578 Chaperone protein gp12 Proteins 0.000 description 1
102000001326 Chemokine CCL4 Human genes 0.000 description 1
108010055165 Chemokine CCL4 Proteins 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
101710091342 Chemotactic peptide Proteins 0.000 description 1
102000009016 Cholera Toxin Human genes 0.000 description 1
108010049048 Cholera Toxin Proteins 0.000 description 1
PHEDXBVPIONUQT-UHFFFAOYSA-N Cocarcinogen A1 Natural products CCCCCCCCCCCCCC(=O)OC1C(C)C2(O)C3C=C(C)C(=O)C3(O)CC(CO)=CC2C2C1(OC(C)=O)C2(C)C PHEDXBVPIONUQT-UHFFFAOYSA-N 0.000 description 1
108700010070 Codon Usage Proteins 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
239000004338 Dichlorodifluoromethane Substances 0.000 description 1
KYHUYMLIVQFXRI-SJPGYWQQSA-N Didemnin B Chemical compound CN([C@H](CC(C)C)C(=O)N[C@@H]1C(=O)N[C@@H]([C@H](CC(=O)O[C@H](C(=O)[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(OC)=CC=2)C(=O)O[C@@H]1C)C(C)C)O)[C@@H](C)CC)C(=O)[C@@H]1CCCN1C(=O)[C@H](C)O KYHUYMLIVQFXRI-SJPGYWQQSA-N 0.000 description 1
OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 description 1
108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 description 1
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
108091066263 DnaJ family Proteins 0.000 description 1
102000039201 DnaJ family Human genes 0.000 description 1
102100029952 Double-strand-break repair protein rad21 homolog Human genes 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
108700032759 Drosophila ft Proteins 0.000 description 1
101100232687 Drosophila melanogaster eIF4A gene Proteins 0.000 description 1
LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
101710103942 Elongation factor 1-alpha Proteins 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
241000792859 Enema Species 0.000 description 1
101710091045 Envelope protein Proteins 0.000 description 1
108700039887 Essential Genes Proteins 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
239000004258 Ethoxyquin Substances 0.000 description 1
102100031562 Excitatory amino acid transporter 2 Human genes 0.000 description 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
108010058643 Fungal Proteins Proteins 0.000 description 1
230000010337 G2 phase Effects 0.000 description 1
230000037060 G2 phase arrest Effects 0.000 description 1
101150116572 GLT-1 gene Proteins 0.000 description 1
JRZJKWGQFNTSRN-UHFFFAOYSA-N Geldanamycin Natural products C1C(C)CC(OC)C(O)C(C)C=C(C)C(OC(N)=O)C(OC)CCC=C(C)C(=O)NC2=CC(=O)C(OC)=C1C2=O JRZJKWGQFNTSRN-UHFFFAOYSA-N 0.000 description 1
208000034951 Genetic Translocation Diseases 0.000 description 1
206010071602 Genetic polymorphism Diseases 0.000 description 1
208000032612 Glial tumor Diseases 0.000 description 1
206010018338 Glioma Diseases 0.000 description 1
102000000340 Glucosyltransferases Human genes 0.000 description 1
108010055629 Glucosyltransferases Proteins 0.000 description 1
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
102100034192 Guanine nucleotide exchange factor MSS4 Human genes 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
108700010908 HIV-1 proteins Proteins 0.000 description 1
108010042283 HSP40 Heat-Shock Proteins Proteins 0.000 description 1
102000004447 HSP40 Heat-Shock Proteins Human genes 0.000 description 1
101710182268 Heat shock protein HSP 90 Proteins 0.000 description 1
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
108010025076 Holoenzymes Proteins 0.000 description 1
101000676246 Homo sapiens 60S ribosomal protein L29 Proteins 0.000 description 1
101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 1
101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 1
101100005713 Homo sapiens CD4 gene Proteins 0.000 description 1
101000898052 Homo sapiens Calnexin Proteins 0.000 description 1
101000584942 Homo sapiens Double-strand-break repair protein rad21 homolog Proteins 0.000 description 1
101001058231 Homo sapiens Gamma-enolase Proteins 0.000 description 1
101001134268 Homo sapiens Guanine nucleotide exchange factor MSS4 Proteins 0.000 description 1
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
101000984710 Homo sapiens Lymphocyte-specific protein 1 Proteins 0.000 description 1
101000576320 Homo sapiens Max-binding protein MNT Proteins 0.000 description 1
101001051490 Homo sapiens Neural cell adhesion molecule L1 Proteins 0.000 description 1
101001130437 Homo sapiens Ras-related protein Rap-2b Proteins 0.000 description 1
101000754924 Homo sapiens Ribosomal oxygenase 1 Proteins 0.000 description 1
101000754919 Homo sapiens Ribosomal oxygenase 2 Proteins 0.000 description 1
101000878981 Homo sapiens Squalene synthase Proteins 0.000 description 1
101000732336 Homo sapiens Transcription factor AP-2 gamma Proteins 0.000 description 1
101000629913 Homo sapiens Translocon-associated protein subunit beta Proteins 0.000 description 1
108010048209 Human Immunodeficiency Virus Proteins Proteins 0.000 description 1
108700020134 Human immunodeficiency virus 1 nef Proteins 0.000 description 1
241000701806 Human papillomavirus Species 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
108700005091 Immunoglobulin Genes Proteins 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
108020005350 Initiator Codon Proteins 0.000 description 1
102100026720 Interferon beta Human genes 0.000 description 1
108010047761 Interferon-alpha Proteins 0.000 description 1
102000006992 Interferon-alpha Human genes 0.000 description 1
108090000467 Interferon-beta Proteins 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
102000000589 Interleukin-1 Human genes 0.000 description 1
108010002352 Interleukin-1 Proteins 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
102000000588 Interleukin-2 Human genes 0.000 description 1
102000000646 Interleukin-3 Human genes 0.000 description 1
108010002386 Interleukin-3 Proteins 0.000 description 1
108090000978 Interleukin-4 Proteins 0.000 description 1
102000004388 Interleukin-4 Human genes 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
102000004889 Interleukin-6 Human genes 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
241000713666 Lentivirus Species 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
239000000232 Lipid Bilayer Substances 0.000 description 1
208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
108090000542 Lymphotoxin-alpha Proteins 0.000 description 1
102000004083 Lymphotoxin-alpha Human genes 0.000 description 1
101800001478 M-beta Proteins 0.000 description 1
102400000234 M-beta Human genes 0.000 description 1
102000043136 MAP kinase family Human genes 0.000 description 1
108091054455 MAP kinase family Proteins 0.000 description 1
108700005089 MHC Class I Genes Proteins 0.000 description 1
108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
235000019759 Maize starch Nutrition 0.000 description 1
206010064912 Malignant transformation Diseases 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
206010027476 Metastases Diseases 0.000 description 1
241000713869 Moloney murine leukemia virus Species 0.000 description 1
102000007474 Multiprotein Complexes Human genes 0.000 description 1
108010085220 Multiprotein Complexes Proteins 0.000 description 1
101000619682 Mus musculus Lymphocyte-specific protein 1 Proteins 0.000 description 1
101100101335 Mus musculus Usp17la gene Proteins 0.000 description 1
XKLMZUWKNUAPSZ-UHFFFAOYSA-N N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide Chemical compound COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC=2C(=CC=CC=2C)C)CC1 XKLMZUWKNUAPSZ-UHFFFAOYSA-N 0.000 description 1
230000004988 N-glycosylation Effects 0.000 description 1
101150081403 NAF1 gene Proteins 0.000 description 1
108010057466 NF-kappa B Proteins 0.000 description 1
206010028813 Nausea Diseases 0.000 description 1
206010029148 Nephrolithiasis Diseases 0.000 description 1
108010025020 Nerve Growth Factor Proteins 0.000 description 1
101100247323 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ras-2 gene Proteins 0.000 description 1
101100544813 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ypt-1 gene Proteins 0.000 description 1
108091093105 Nuclear DNA Proteins 0.000 description 1
102000003789 Nuclear pore complex proteins Human genes 0.000 description 1
108090000163 Nuclear pore complex proteins Proteins 0.000 description 1
208000001388 Opportunistic Infections Diseases 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
241001631646 Papillomaviridae Species 0.000 description 1
206010034133 Pathogen resistance Diseases 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
102000002508 Peptide Elongation Factors Human genes 0.000 description 1
108010068204 Peptide Elongation Factors Proteins 0.000 description 1
108010067902 Peptide Library Proteins 0.000 description 1
102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
108010047620 Phytohemagglutinins Proteins 0.000 description 1
ZQLBCAUKNYXILZ-UGKGYDQZSA-N Piericidin A Natural products COc1nc(CC=C(/C)C=CCC(=C[C@H](C)[C@@H](O)C(=CC)C)C)c(C)c(O)c1OC ZQLBCAUKNYXILZ-UGKGYDQZSA-N 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
241001505332 Polyomavirus sp. Species 0.000 description 1
229920002642 Polysorbate 65 Polymers 0.000 description 1
108010068086 Polyubiquitin Proteins 0.000 description 1
102100037935 Polyubiquitin-C Human genes 0.000 description 1
101710102575 Pre-neck appendage protein Proteins 0.000 description 1
101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
101710118538 Protease Proteins 0.000 description 1
102000001253 Protein Kinase Human genes 0.000 description 1
101710192141 Protein Nef Proteins 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
101710188315 Protein X Proteins 0.000 description 1
101710150114 Protein rep Proteins 0.000 description 1
108010067787 Proteoglycans Proteins 0.000 description 1
102000016611 Proteoglycans Human genes 0.000 description 1
101710097451 Putative G-protein coupled receptor Proteins 0.000 description 1
102100039117 Putative vomeronasal receptor-like protein 4 Human genes 0.000 description 1
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
101150004420 RAB3A gene Proteins 0.000 description 1
108090000944 RNA Helicases Proteins 0.000 description 1
102000004409 RNA Helicases Human genes 0.000 description 1
102000044126 RNA-Binding Proteins Human genes 0.000 description 1
108700020471 RNA-Binding Proteins Proteins 0.000 description 1
230000004570 RNA-binding Effects 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
101001058233 Rattus norvegicus Gamma-enolase Proteins 0.000 description 1
101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
230000010799 Receptor Interactions Effects 0.000 description 1
229940123934 Reductase inhibitor Drugs 0.000 description 1
101710152114 Replication protein Proteins 0.000 description 1
HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
102100022135 S-arrestin Human genes 0.000 description 1
101710117586 S-arrestin Proteins 0.000 description 1
101150033156 SSR2 gene Proteins 0.000 description 1
241000235346 Schizosaccharomyces Species 0.000 description 1
108010074686 Selenoproteins Proteins 0.000 description 1
102000008114 Selenoproteins Human genes 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
241000713311 Simian immunodeficiency virus Species 0.000 description 1
101150041420 Slc1a2 gene Proteins 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
101100273965 Solanum lycopersicum HCR9-0 gene Proteins 0.000 description 1
101001039853 Sonchus yellow net virus Matrix protein Proteins 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
102000005465 Stathmin Human genes 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
230000006044 T cell activation Effects 0.000 description 1
238000012233 TRIzol extraction Methods 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
102100035115 Testin Human genes 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
108010018242 Transcription Factor AP-1 Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
102100023132 Transcription factor Jun Human genes 0.000 description 1
108020004566 Transfer RNA Proteins 0.000 description 1
108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
102100026229 Translocon-associated protein subunit beta Human genes 0.000 description 1
206010052779 Transplant rejections Diseases 0.000 description 1
239000007984 Tris EDTA buffer Substances 0.000 description 1
108090000704 Tubulin Proteins 0.000 description 1
108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
241000269370 Xenopus <genus> Species 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
230000035508 accumulation Effects 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
235000011054 acetic acid Nutrition 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
108091006088 activator proteins Proteins 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
108091005764 adaptor proteins Proteins 0.000 description 1
102000035181 adaptor proteins Human genes 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
239000008272 agar Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
229940040563 agaric acid Drugs 0.000 description 1
230000032683 aging Effects 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
230000008841 allosteric interaction Effects 0.000 description 1
239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
230000009435 amidation Effects 0.000 description 1
238000007112 amidation reaction Methods 0.000 description 1
230000003042 antagnostic effect Effects 0.000 description 1
239000002259 anti human immunodeficiency virus agent Substances 0.000 description 1
230000000843 anti-fungal effect Effects 0.000 description 1
229940124411 anti-hiv antiviral agent Drugs 0.000 description 1
230000003302 anti-idiotype Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000002787 antisense oligonuctleotide Substances 0.000 description 1
239000003443 antiviral agent Substances 0.000 description 1
239000008135 aqueous vehicle Substances 0.000 description 1
239000004760 aramid Substances 0.000 description 1
229920003235 aromatic polyamide Polymers 0.000 description 1
239000000305 astragalus gummifer gum Substances 0.000 description 1
230000001363 autoimmune Effects 0.000 description 1
238000011130 autologous cell therapy Methods 0.000 description 1
230000028600 axonogenesis Effects 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
210000000270 basal cell Anatomy 0.000 description 1
210000004227 basal ganglia Anatomy 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
208000036815 beta tubulin Diseases 0.000 description 1
230000002457 bidirectional effect Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000002715 bioenergetic effect Effects 0.000 description 1
210000002459 blastocyst Anatomy 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
229940112869 bone morphogenetic protein Drugs 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
239000004067 bulking agent Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
229960002504 capsaicin Drugs 0.000 description 1
235000017663 capsaicin Nutrition 0.000 description 1
150000001720 carbohydrates Chemical group 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
229960004424 carbon dioxide Drugs 0.000 description 1
210000004413 cardiac myocyte Anatomy 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
210000004970 cd4 cell Anatomy 0.000 description 1
230000006369 cell cycle progression Effects 0.000 description 1
230000011712 cell development Effects 0.000 description 1
230000032823 cell division Effects 0.000 description 1
108091092328 cellular RNA Proteins 0.000 description 1
201000010881 cervical cancer Diseases 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000005482 chemotactic factor Substances 0.000 description 1
208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
238000003501 co-culture Methods 0.000 description 1
230000004186 co-expression Effects 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
239000005516 coenzyme A Substances 0.000 description 1
235000017471 coenzyme Q10 Nutrition 0.000 description 1
229940093530 coenzyme a Drugs 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
235000008504 concentrate Nutrition 0.000 description 1
238000004624 confocal microscopy Methods 0.000 description 1
108091036078 conserved sequence Proteins 0.000 description 1
239000013068 control sample Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
238000012258 culturing Methods 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
230000000120 cytopathologic effect Effects 0.000 description 1
230000021040 cytoplasmic transport Effects 0.000 description 1
210000004292 cytoskeleton Anatomy 0.000 description 1
230000034994 death Effects 0.000 description 1
238000006114 decarboxylation reaction Methods 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
239000003405 delayed action preparation Substances 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000000779 depleting effect Effects 0.000 description 1
238000001212 derivatisation Methods 0.000 description 1
230000000368 destabilizing effect Effects 0.000 description 1
230000009504 deubiquitination Effects 0.000 description 1
PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
229940042935 dichlorodifluoromethane Drugs 0.000 description 1
229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
KYHUYMLIVQFXRI-UHFFFAOYSA-N didemnin B Natural products CC1OC(=O)C(CC=2C=CC(OC)=CC=2)N(C)C(=O)C2CCCN2C(=O)C(CC(C)C)NC(=O)C(C)C(=O)C(C(C)C)OC(=O)CC(O)C(C(C)CC)NC(=O)C1NC(=O)C(CC(C)C)N(C)C(=O)C1CCCN1C(=O)C(C)O KYHUYMLIVQFXRI-UHFFFAOYSA-N 0.000 description 1
108010061297 didemnins Proteins 0.000 description 1
239000005546 dideoxynucleotide Substances 0.000 description 1
230000029087 digestion Effects 0.000 description 1
108010079167 dihydrolipoamide succinyltransferase Proteins 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
229910001882 dioxygen Inorganic materials 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
238000009826 distribution Methods 0.000 description 1
239000000890 drug combination Substances 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
230000027721 electron transport chain Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
239000007920 enema Substances 0.000 description 1
229940079360 enema for constipation Drugs 0.000 description 1
108700004025 env Genes Proteins 0.000 description 1
101150030339 env gene Proteins 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
229940093500 ethoxyquin Drugs 0.000 description 1
235000019285 ethoxyquin Nutrition 0.000 description 1
LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
229940093471 ethyl oleate Drugs 0.000 description 1
210000004265 eukaryotic small ribosome subunit Anatomy 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
230000028023 exocytosis Effects 0.000 description 1
108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
210000002744 extracellular matrix Anatomy 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
239000000945 filler Substances 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
230000037406 food intake Effects 0.000 description 1
239000012458 free base Substances 0.000 description 1
230000005714 functional activity Effects 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
239000007789 gas Substances 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
QTQAWLPCGQOSGP-GBTDJJJQSA-N geldanamycin Chemical compound N1C(=O)\C(C)=C/C=C\[C@@H](OC)[C@H](OC(N)=O)\C(C)=C/[C@@H](C)[C@@H](O)[C@H](OC)C[C@@H](C)CC2=C(OC)C(=O)C=C1C2=O QTQAWLPCGQOSGP-GBTDJJJQSA-N 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
230000005182 global health Effects 0.000 description 1
230000006377 glucose transport Effects 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
230000002414 glycolytic effect Effects 0.000 description 1
210000002288 golgi apparatus Anatomy 0.000 description 1
239000008202 granule composition Substances 0.000 description 1
210000003714 granulocyte Anatomy 0.000 description 1
239000005090 green fluorescent protein Substances 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
229940025294 hemin Drugs 0.000 description 1
BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 1
238000009957 hemming Methods 0.000 description 1
231100000086 high toxicity Toxicity 0.000 description 1
239000000710 homodimer Substances 0.000 description 1
102000056907 human ARF3 Human genes 0.000 description 1
102000045875 human BMP1 Human genes 0.000 description 1
102000057386 human CANX Human genes 0.000 description 1
102000047582 human L1CAM Human genes 0.000 description 1
102000051793 human LSP1 Human genes 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
229920001600 hydrophobic polymer Polymers 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
230000028993 immune response Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
230000001861 immunosuppressant effect Effects 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
239000007943 implant Substances 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
229960001936 indinavir Drugs 0.000 description 1
CBVCZFGXHXORBI-PXQQMZJSSA-N indinavir Chemical compound C([C@H](N(CC1)C[C@@H](O)C[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H]2C3=CC=CC=C3C[C@H]2O)C(=O)NC(C)(C)C)N1CC1=CC=CN=C1 CBVCZFGXHXORBI-PXQQMZJSSA-N 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000004941 influx Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
239000003999 initiator Substances 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
229960003130 interferon gamma Drugs 0.000 description 1
229940047124 interferons Drugs 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
238000007914 intraventricular administration Methods 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
230000005865 ionizing radiation Effects 0.000 description 1
PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 1
PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 1
FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
210000000231 kidney cortex Anatomy 0.000 description 1
239000004922 lacquer Substances 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
231100001231 less toxic Toxicity 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
229940057995 liquid paraffin Drugs 0.000 description 1
230000005817 liver abnormality Effects 0.000 description 1
231100000053 low toxicity Toxicity 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
210000003712 lysosome Anatomy 0.000 description 1
230000001868 lysosomic effect Effects 0.000 description 1
102100034702 mRNA decay activator protein ZFP36L1 Human genes 0.000 description 1
239000003120 macrolide antibiotic agent Substances 0.000 description 1
229940041033 macrolides Drugs 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
230000036212 malign transformation Effects 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
210000003593 megakaryocyte Anatomy 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
230000009401 metastasis Effects 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
210000001700 mitochondrial membrane Anatomy 0.000 description 1
239000003226 mitogen Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
239000000178 monomer Substances 0.000 description 1
VYGYNVZNSSTDLJ-HKCOAVLJSA-N monorden Natural products CC1CC2OC2C=C/C=C/C(=O)CC3C(C(=CC(=C3Cl)O)O)C(=O)O1 VYGYNVZNSSTDLJ-HKCOAVLJSA-N 0.000 description 1
229940105132 myristate Drugs 0.000 description 1
230000007498 myristoylation Effects 0.000 description 1
OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 1
230000008693 nausea Effects 0.000 description 1
239000006199 nebulizer Substances 0.000 description 1
108700004028 nef Genes Proteins 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
229940053128 nerve growth factor Drugs 0.000 description 1
230000008271 nervous system development Effects 0.000 description 1
210000005155 neural progenitor cell Anatomy 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
231100000956 nontoxicity Toxicity 0.000 description 1
230000004942 nuclear accumulation Effects 0.000 description 1
210000000633 nuclear envelope Anatomy 0.000 description 1
230000030147 nuclear export Effects 0.000 description 1
210000004492 nuclear pore Anatomy 0.000 description 1
229920002113 octoxynol Polymers 0.000 description 1
210000000287 oocyte Anatomy 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
229920000620 organic polymer Polymers 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
238000012261 overproduction Methods 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
238000005895 oxidative decarboxylation reaction Methods 0.000 description 1
YFZOUMNUDGGHIW-UHFFFAOYSA-M p-chloromercuribenzoic acid Chemical compound OC(=O)C1=CC=C([Hg]Cl)C=C1 YFZOUMNUDGGHIW-UHFFFAOYSA-M 0.000 description 1
101800002723 p18 Proteins 0.000 description 1
230000026792 palmitoylation Effects 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
208000035824 paresthesia Diseases 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
229960000482 pethidine Drugs 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
OHFDBBFDFZXHJQ-UHFFFAOYSA-N phenylarsane Chemical compound [AsH2]C1=CC=CC=C1 OHFDBBFDFZXHJQ-UHFFFAOYSA-N 0.000 description 1
QGVLYPPODPLXMB-QXYKVGAMSA-N phorbol Natural products C[C@@H]1[C@@H](O)[C@]2(O)[C@H]([C@H]3C=C(CO)C[C@@]4(O)[C@H](C=C(C)C4=O)[C@@]13O)C2(C)C QGVLYPPODPLXMB-QXYKVGAMSA-N 0.000 description 1
PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 1
RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
150000008300 phosphoramidites Chemical class 0.000 description 1
DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 1
230000001885 phytohemagglutinin Effects 0.000 description 1
BBLGCDSLCDDALX-LKGBESRRSA-N piericidin A Chemical compound COC=1NC(C\C=C(/C)C\C=C\C(\C)=C\[C@@H](C)[C@@H](O)C(\C)=C\C)=C(C)C(=O)C=1OC BBLGCDSLCDDALX-LKGBESRRSA-N 0.000 description 1
239000006187 pill Substances 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
230000003169 placental effect Effects 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
229940068886 polyethylene glycol 300 Drugs 0.000 description 1
229920001195 polyisoprene Polymers 0.000 description 1
239000001816 polyoxyethylene sorbitan tristearate Substances 0.000 description 1
235000010988 polyoxyethylene sorbitan tristearate Nutrition 0.000 description 1
210000002729 polyribosome Anatomy 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
150000004804 polysaccharides Chemical class 0.000 description 1
229940099511 polysorbate 65 Drugs 0.000 description 1
230000034190 positive regulation of NF-kappaB transcription factor activity Effects 0.000 description 1
230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 1
230000001323 posttranslational effect Effects 0.000 description 1
229920001592 potato starch Polymers 0.000 description 1
230000013823 prenylation Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
238000002203 pretreatment Methods 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
239000003380 propellant Substances 0.000 description 1
230000004853 protein function Effects 0.000 description 1
108060006633 protein kinase Proteins 0.000 description 1
230000007398 protein translocation Effects 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
239000003586 protic polar solvent Substances 0.000 description 1
150000003212 purines Chemical class 0.000 description 1
125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
229960001285 quercetin Drugs 0.000 description 1
235000005875 quercetin Nutrition 0.000 description 1
AECPBJMOGBFQDN-YMYQVXQQSA-N radicicol Chemical compound C1CCCC(=O)C[C@H]2[C@H](Cl)C(=O)CC(=O)[C@H]2C(=O)O[C@H](C)C[C@H]2O[C@@H]21 AECPBJMOGBFQDN-YMYQVXQQSA-N 0.000 description 1
229930192524 radicicol Natural products 0.000 description 1
102000005912 ran GTP Binding Protein Human genes 0.000 description 1
108010005597 ran GTP Binding Protein Proteins 0.000 description 1
229960000213 ranolazine Drugs 0.000 description 1
102000016914 ras Proteins Human genes 0.000 description 1
108010014186 ras Proteins Proteins 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
230000008844 regulatory mechanism Effects 0.000 description 1
230000001850 reproductive effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
108700004030 rev Genes Proteins 0.000 description 1
101150098213 rev gene Proteins 0.000 description 1
238000012552 review Methods 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
210000004708 ribosome subunit Anatomy 0.000 description 1
229940100486 rice starch Drugs 0.000 description 1
229960000311 ritonavir Drugs 0.000 description 1
NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 description 1
229940080817 rotenone Drugs 0.000 description 1
JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 1
102220240796 rs553605556 Human genes 0.000 description 1
229960001852 saquinavir Drugs 0.000 description 1
QWAXKHKRTORLEM-UGJKXSETSA-N saquinavir Chemical compound C([C@@H]([C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)C=1N=C2C=CC=CC2=CC=1)C1=CC=CC=C1 QWAXKHKRTORLEM-UGJKXSETSA-N 0.000 description 1
238000012216 screening Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
208000017520 skin disease Diseases 0.000 description 1
239000002002 slurry Substances 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
235000019333 sodium laurylsulphate Nutrition 0.000 description 1
CMZUMMUJMWNLFH-UHFFFAOYSA-N sodium metavanadate Chemical compound [Na+].[O-][V](=O)=O CMZUMMUJMWNLFH-UHFFFAOYSA-N 0.000 description 1
239000007901 soft capsule Substances 0.000 description 1
239000012439 solid excipient Substances 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
241000894007 species Species 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
210000000278 spinal cord Anatomy 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
239000007921 spray Substances 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
230000010473 stable expression Effects 0.000 description 1
102000005963 steroid binding proteins Human genes 0.000 description 1
108020003178 steroid binding proteins Proteins 0.000 description 1
102000005969 steroid hormone receptors Human genes 0.000 description 1
108020003113 steroid hormone receptors Proteins 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
230000035882 stress Effects 0.000 description 1
210000002536 stromal cell Anatomy 0.000 description 1
239000001384 succinic acid Substances 0.000 description 1
235000011044 succinic acid Nutrition 0.000 description 1
VNOYUJKHFWYWIR-ITIYDSSPSA-N succinyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 VNOYUJKHFWYWIR-ITIYDSSPSA-N 0.000 description 1
230000035322 succinylation Effects 0.000 description 1
238000010613 succinylation reaction Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
238000009495 sugar coating Methods 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000002511 suppository base Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
208000010648 susceptibility to HIV infection Diseases 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
108700004027 tat Genes Proteins 0.000 description 1
101150098170 tat gene Proteins 0.000 description 1
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
229960000278 theophylline Drugs 0.000 description 1
231100001274 therapeutic index Toxicity 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
239000005495 thyroid hormone Substances 0.000 description 1
229940036555 thyroid hormone Drugs 0.000 description 1
239000003104 tissue culture media Substances 0.000 description 1
239000004408 titanium dioxide Substances 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
108091006107 transcriptional repressors Proteins 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
238000003146 transient transfection Methods 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
229940029284 trichlorofluoromethane Drugs 0.000 description 1
229940035722 triiodothyronine Drugs 0.000 description 1
PZYFJWVGRGEWGO-UHFFFAOYSA-N trisodium;hydrogen peroxide;trioxido(oxo)vanadium Chemical compound [Na+].[Na+].[Na+].OO.OO.OO.[O-][V]([O-])([O-])=O PZYFJWVGRGEWGO-UHFFFAOYSA-N 0.000 description 1
210000002993 trophoblast Anatomy 0.000 description 1
230000010415 tropism Effects 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
239000000225 tumor suppressor protein Substances 0.000 description 1
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
150000003669 ubiquinones Chemical class 0.000 description 1
230000034512 ubiquitination Effects 0.000 description 1
238000010798 ubiquitination Methods 0.000 description 1
LSGOVYNHVSXFFJ-UHFFFAOYSA-N vanadate(3-) Chemical compound [O-][V]([O-])([O-])=O LSGOVYNHVSXFFJ-UHFFFAOYSA-N 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
230000007502 viral entry Effects 0.000 description 1
230000009220 viral host cell interaction Effects 0.000 description 1
QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
235000005282 vitamin D3 Nutrition 0.000 description 1
239000011647 vitamin D3 Substances 0.000 description 1
229940021056 vitamin d3 Drugs 0.000 description 1
230000008673 vomiting Effects 0.000 description 1
238000001262 western blot Methods 0.000 description 1
229940100445 wheat starch Drugs 0.000 description 1
QDLHCMPXEPAAMD-QAIWCSMKSA-N wortmannin Chemical compound C1([C@]2(C)C3=C(C4=O)OC=C3C(=O)O[C@@H]2COC)=C4[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O QDLHCMPXEPAAMD-QAIWCSMKSA-N 0.000 description 1
QDLHCMPXEPAAMD-UHFFFAOYSA-N wortmannin Natural products COCC1OC(=O)C2=COC(C3=O)=C2C1(C)C1=C3C2CCC(=O)C2(C)CC1OC(C)=O QDLHCMPXEPAAMD-UHFFFAOYSA-N 0.000 description 1
229910000166 zirconium phosphate Inorganic materials 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Toxicology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

JP2001520868A 1999-09-01 2000-09-01 ヒト細胞遺伝子をダウンレギュレートすることにより、ヒト免疫不全ウイルス感染を阻止するための組成物および方法 Pending JP2003510033A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US38818299A	1999-09-01	1999-09-01
US09/388,182		1999-09-01
PCT/US2000/024262 WO2001016322A2 (fr)	1999-09-01	2000-09-01	Compositions et procedes d'inhibition de l'infection au virus de l'immunodeficience humaine, par regulation restrictive de genes cellulaires humains

Publications (1)

Publication Number	Publication Date
JP2003510033A true JP2003510033A (ja)	2003-03-18

Family

ID=23533027

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2001520868A Pending JP2003510033A (ja)	1999-09-01	2000-09-01	ヒト細胞遺伝子をダウンレギュレートすることにより、ヒト免疫不全ウイルス感染を阻止するための組成物および方法

Country Status (6)

Country	Link
EP (1)	EP1238072A2 (fr)
JP (1)	JP2003510033A (fr)
AU (1)	AU771546B2 (fr)
CA (1)	CA2382030A1 (fr)
IL (1)	IL148225A0 (fr)
WO (1)	WO2001016322A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2013523662A (ja) *	2010-04-01	2013-06-17	セントロデインジエニエリアジエネテイカイバイオテクノロジア	哺乳動物及びヒトの細胞においてｈｉｖ複製を阻害する方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030087273A1 (en) *	2001-06-29	2003-05-08	Holzmayer Tanya A.	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
BR112016016130A2 (pt)	2014-01-10	2017-08-08	Glaxosmithkline Ip No 2 Ltd	Compostos e métodos
AU2015204452A1 (en)	2014-01-13	2016-08-11	Berg Llc	Enolase 1 (Eno1) compositions and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL83003A (en) *	1986-07-01	1995-07-31	Genetics Inst	Osteoinductive factors
US6071743A (en) *	1997-06-02	2000-06-06	Subsidiary No. 3, Inc.	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes

2000
- 2000-09-01 IL IL14822500A patent/IL148225A0/xx unknown
- 2000-09-01 EP EP00961525A patent/EP1238072A2/fr not_active Withdrawn
- 2000-09-01 WO PCT/US2000/024262 patent/WO2001016322A2/fr not_active Ceased
- 2000-09-01 AU AU73466/00A patent/AU771546B2/en not_active Ceased
- 2000-09-01 CA CA002382030A patent/CA2382030A1/fr not_active Abandoned
- 2000-09-01 JP JP2001520868A patent/JP2003510033A/ja active Pending

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2013523662A (ja) *	2010-04-01	2013-06-17	セントロデインジエニエリアジエネテイカイバイオテクノロジア	哺乳動物及びヒトの細胞においてｈｉｖ複製を阻害する方法
JP2016121172A (ja) *	2010-04-01	2016-07-07	セントロデインジエニエリアジエネテイカイバイオテクノロジア	哺乳動物及びヒトの細胞においてｈｉｖ複製を阻害する方法

Also Published As

Publication number	Publication date
AU7346600A (en)	2001-03-26
IL148225A0 (en)	2002-09-12
AU771546B2 (en)	2004-03-25
CA2382030A1 (fr)	2001-03-08
WO2001016322A3 (fr)	2002-07-11
WO2001016322A2 (fr)	2001-03-08
EP1238072A2 (fr)	2002-09-11

Legal Events

Date

Code

Title

Description

2004-03-19

A711

Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20040318

2005-07-20

A131

Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050719

2005-12-14

A02

Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20051213

Publication	Publication Date	Title
Mizuki et al.	1998	Functional modules and expression of mouse p40 phox and p67phox, SH3‐domain‐containing proteins involved in the phagocyte NADPH oxidase complex
JP4180114B2 (ja)	2008-11-12	Ｔｎｆ受容体関連因子（ｔｒａｆ）のモジュレーター、その製造法および使用
US20090258794A1 (en)	2009-10-15	Apoptosis methods, genes and proteins
KR100536394B1 (ko)	2006-04-21	Fas/ap01수용체들의기능조절인자
US6071743A (en)	2000-06-06	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
JP2002525081A (ja)	2002-08-13	低酸素により調節される遺伝子転写に特徴的な配列
CA2496891A1 (fr)	2004-03-18	Nouveau lacs de proteine cytosquelette associee a actine
JP2003510033A (ja)	2003-03-18	ヒト細胞遺伝子をダウンレギュレートすることにより、ヒト免疫不全ウイルス感染を阻止するための組成物および方法
US6537972B1 (en)	2003-03-25	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
JPWO2000029571A1 (ja)	2002-02-26	新規膜貫通蛋白質をコードする遺伝子
US6613506B1 (en)	2003-09-02	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
JP2001511645A (ja)	2001-08-14	ヒトＣ５ａ様受容体
US20020150953A1 (en)	2002-10-17	Methods and compositions relating to muscle selective calcineurin interacting protein (MCIP)
WO2001016323A2 (fr)	2001-03-08	Compositions et procedes d'inhibition de l'infection due au virus de l'immunodeficience humaine a l'aide de genes cellulaires humains a regulation negative
JP2007523608A (ja)	2007-08-23	サイクリックａｍｐ応答エレメントアクティベータータンパク質およびそれに関連する使用
CA2264544A1 (fr)	1998-04-02	Proteines sm snrnp
WO2004061088A2 (fr)	2004-07-22	Compositions et methodes d'inhibition d'une infection par le virus de l'immunodeficience humaine par regulation vers l'aval de genes cellulaires humains
CA2349761A1 (fr)	2000-05-18	Genes associes a la synthese de corticosteroides
WO2004053094A2 (fr)	2004-06-24	Compositions et procedes permettant d'inhiber l'infection par le virus de l'immunodeficience acquise par freination des genes cellulaires humains
WO2005044980A2 (fr)	2005-05-19	Proteine zap et compositions et methodes associees
AU3508101A (en)	2001-06-21	Modulators of TNF receptor associated factor (TRAF), their preparation and use
WO2002017949A9 (fr)	2002-09-19	Nouvelles fonctions de dp214
ZA200101566B (en)	2003-06-26	Sequences characteristic of hypoxia-regulated gene transcription.